Meibomian Gland Dysfunction-Related Dry Eye
Conditions
Interventions
Observation group:none
Control group:none
Sponsors
Qilu Hospital of Shandong University Dezhou Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: It simultaneously meets the diagnostic requirements of the 2020 Chinese Expert Consensus on Dry Eye and the 2023 Chinese Expert Consensus on Meibomian Gland Dysfunction (MGD). Age >=18 years old, <=60 years old; No major systemic diseases; No eye medications have been used in the past three months. There has been no history of eye surgery or trauma in the past six months. Not worn contact lenses in the past six months; Informed consent and signing of written documents.
Exclusion criteria
Exclusion criteria: Combined with other ocular surface lesions or ocular structural abnormalities; Patients with dry eyes secondary to rheumatic immune diseases; There are contraindications for intense pulsed light (OPT) treatment. Taking drugs that may interfere with tear secretion in the past three months; Women who are pregnant or breastfeeding; Those currently participating in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Non Invasive Tear Break Up Time; | — |
Secondary
| Measure | Time frame |
|---|---|
| Tear meniscus height;Meibomian gland imaging;Chinese Dry Eye Questionnaire Scale;Tear secretion volume;Score for the characteristics of meibomian gland secretions;Expression of various lipids in tears;Positive rate of mites; | — |
Countries
China
Contacts
Public ContactChengcheng Zhu
Qilu Hospital of Shandong University Dezhou Hospital
Outcome results
None listed